Australia markets open in 6 hours 41 minutes
  • ALL ORDS

    7,587.40
    +24.90 (+0.33%)
     
  • AUD/USD

    0.7095
    -0.0047 (-0.66%)
     
  • ASX 200

    7,256.00
    +16.20 (+0.22%)
     
  • OIL

    67.01
    -2.94 (-4.20%)
     
  • GOLD

    1,782.80
    -2.40 (-0.13%)
     
  • BTC-AUD

    80,484.91
    -352.48 (-0.44%)
     
  • CMC Crypto 200

    1,456.27
    +13.50 (+0.94%)
     

Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape Report 2018-2026 - ResearchAndMarkets.com

·4-min read

DUBLIN, October 28, 2021--(BUSINESS WIRE)--The "Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2021, provides comprehensive insights into Dry Age-Related Macular Degeneration pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Dry Age-Related Macular Degeneration market size and drug sales. It also provides insights into Dry Age-Related Macular Degeneration epidemiology and late-stage pipeline.

This research covers the following - Dry Age-Related Macular Degeneration treatment options, Dry Age-Related Macular Degeneration late-stage clinical trials pipeline, Dry Age-Related Macular Degeneration prevalence by countries, Dry Age-Related Macular Degeneration market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

  • Countries: Germany, France, Italy, Spain, UK, Europe

  • Dry Age-Related Macular Degeneration pipeline: Find out drugs in clinical trials for the treatment of Dry Age-Related Macular Degeneration by development phase 3, phase 2, by pharmacological class and company

  • Dry Age-Related Macular Degeneration epidemiology: Find out the number of patients diagnosed (prevalence) with Dry Age-Related Macular Degeneration by countries

  • Dry Age-Related Macular Degeneration drugs: Identify key drugs marketed and prescribed for Dry Age-Related Macular Degeneration in the US, including trade name, molecule name, and company

  • Dry Age-Related Macular Degeneration drugs sales: Find out the sales value for Dry Age-Related Macular Degeneration drugs by countries

  • Dry Age-Related Macular Degeneration market valuations: Find out the market size for Dry Age-Related Macular Degeneration drugs in 2020 by countries. Find out how the market advanced from 2018 and forecast to 2026

  • Dry Age-Related Macular Degeneration drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research:

  • Evaluate commercial market opportunities for Dry Age-Related Macular Degeneration drugs

  • Synthesize insights for business development & licensing

  • Track market size, competitor drug sales, market shares in Dry Age-Related Macular Degeneration market

  • Develop in-depth knowledge of competition and markets

  • Analyze Dry Age-Related Macular Degeneration drug sales data to update your brand planning trackers

  • Develop tactics and strategies to take advantage of opportunities in the market

  • Track Market Events and Trends and analyze key events in Dry Age-Related Macular Degeneration market

  • Develop forecast models, healthcare frameworks, or economic models

  • Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Dry Age-Related Macular Degeneration Treatment Options

2. Dry Age-Related Macular Degeneration Pipeline Insights

2.1. Dry Age-Related Macular Degeneration Phase 3 Clinical Trials

2.2. Dry Age-Related Macular Degeneration Phase 2 Clinical Trials

2.3. Dry Age-Related Macular Degeneration Phase 1 Clinical Trials

3. Dry Age-Related Macular Degeneration Epidemiology Analysis by Countries

4. Germany Dry Age-Related Macular Degeneration Market Insights

4.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Germany

4.2. Germany Dry Age-Related Macular Degeneration Market Size & Forecast

4.3. Germany Dry Age-Related Macular Degeneration Drugs Sales Forecast

4.4. Germany Dry Age-Related Macular Degeneration Market Share Analysis

5. France Dry Age-Related Macular Degeneration Market Insights

5.1. Marketed Drugs for Dry Age-Related Macular Degeneration in France

5.2. France Dry Age-Related Macular Degeneration Market Size & Forecast

5.3. France Dry Age-Related Macular Degeneration Product Sales Forecast

5.4. France Dry Age-Related Macular Degeneration Market Share Analysis

6. Italy Dry Age-Related Macular Degeneration Market Insights

6.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Italy

6.2. Italy Dry Age-Related Macular Degeneration Market Size & Forecast

6.3. Italy Dry Age-Related Macular Degeneration Product Sales Forecast

6.4. Italy Dry Age-Related Macular Degeneration Market Share Analysis

7. Spain Dry Age-Related Macular Degeneration Market Insights

7.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Spain

7.2. Spain Dry Age-Related Macular Degeneration Market Size & Forecast

7.3. Spain Dry Age-Related Macular Degeneration Product Sales Forecast

7.4. Spain Dry Age-Related Macular Degeneration Market Share Analysis

8. UK Dry Age-Related Macular Degeneration Market Insights

8.1. Marketed Drugs for Dry Age-Related Macular Degeneration in UK

8.2. UK Dry Age-Related Macular Degeneration Market Size & Forecast

8.3. UK Dry Age-Related Macular Degeneration Product Sales Forecast

8.4. UK Dry Age-Related Macular Degeneration Market Share Analysis

9. Europe Dry Age-Related Macular Degeneration Market Insights

9.1. Europe Dry Age-Related Macular Degeneration Market Size & Forecast

9.2. Europe Dry Age-Related Macular Degeneration Product Sales Forecast

9.3. Europe Dry Age-Related Macular Degeneration Market Share Analysis

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/j1hyz7

View source version on businesswire.com: https://www.businesswire.com/news/home/20211028005481/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting